PM
Insider
Paul A Mahon
EVP & GENERAL COUNSELPaul A Mahon (EVP & GENERAL COUNSEL) filed 24 Form 4 reports in the trailing twelve months (0 purchases, 24 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $5.5M of UTHR (10,742 sh across 4 lots, as filed), executed Dec 24 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
24
0 buys · 24 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$109.0M
shares × price, as filed
Last traded
Sep 17
Filed Sep 18
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $158.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
24 filings
Sector per market data · by filing · past 12 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$4.8M8,150 sh across 6 lots
Exec May 7
Filed May 7 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.8M
8,300 sh across 5 lots
Exec Apr 16
Filed Apr 16 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.7M
8,300 sh across 11 lots
Exec Apr 2
Filed Apr 2 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.4M
8,220 sh across 6 lots
Exec Mar 19
Filed Mar 19 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $3.9M
8,100 sh across 8 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.0M
8,300 sh across 8 lots
Exec Feb 19
Filed Feb 19 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.0M
8,300 sh across 6 lots
Exec Feb 5
Filed Feb 5 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $3.9M
8,260 sh across 5 lots
Exec Jan 15
Filed Jan 15 · 5:30 PM ET More filings →